Latest stories on SRZN
Surrozen, Inc./DE (SRZN) files 8-K
SEC 8-K50 · neutralgeneral
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
GlobeNewswire28 · bearishgeneral
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
Business Insider28 · bearishgeneral
Top Biotech Stock: Guggenheim Names Surrozen as Best Pick
Investing.com Markets64 · neutralanalyst
Surrozen advances diabetic macular edema candidate into clinic after IND clearance
Seeking Alpha67 · bullishproduct/pr
Surrozen announces FDA clearance of IND application for SZN-8141
The Fly67 · bullishproduct/pr
Surrozen, Inc./DE (SRZN) files 8-K
SEC 8-K50 · neutralgeneral
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
GlobeNewswire67 · bullishproduct/pr
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
Business Insider67 · bullishproduct/pr
H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation
Investing.com Analyst Ratings63 · neutralanalyst
Surrozen price target raised to $54 from $44 at H.C. Wainwright
The Fly65 · bullishanalyst
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
Stocktwits News63 · neutralearnings
Surrozen, Inc. (SRZN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Surrozen submits investigational new drug application for SZN-8141
The Fly63 · neutralproduct/pr
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
GlobeNewswire63 · neutralproduct/pr
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
Business Insider63 · neutralproduct/pr
Surrozen to Present at Upcoming Healthcare Investor Conferences
Business Insider56 · neutralproduct/pr
Surrozen to Present at Upcoming Healthcare Investor Conferences
GlobeNewswire56 · neutralgeneral
William Blair initiates Surrozen stock with Outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Surrozen initiated with an Outperform at William Blair
The Fly61 · neutralanalyst
H.C. Wainwright reiterates Surrozen stock rating at buy, $44 target
Investing.com Analyst Ratings61 · neutralanalyst
Surrozen GAAP EPS of -$0.41
Seeking Alpha34 · bearishearnings